why isn't semaglutide working for me anymore am I not losing weight on (Ozempic/Wegovy)? 12 Reasons You're Not Losing

Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are contraindicated due to mechanistic overlap with GLP-1 agonists

Janzen, V

DOI: 10.1111/dom.16229

Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated

Medical documentation: Prescription records for all medications Doctors notes about medication changes Records of reported side effects Diagnostic testing and when it was performed How this affects your case: If symptoms began with the first drug: Clear temporal relationship Strong causation argument May have claims against that manufacturer If symptoms worsened with each subsequent drug: Cumulative damage theory May have claims against multiple manufacturers Important to show progression If symptoms appeared only after starting the second or third drug: Still valid claim May need to address why earlier drug was tolerated Focus on the drug most directly linked to injury Causation analysis: Your medical experts will examine: Which drug you were taking when symptoms began Whether cumulative exposure contributed Whether one drugs effects sensitized you to another The biological plausibility of the timeline Multiple defendants: If you took medications from both Novo Nordisk and Eli Lilly, you may have claims against both companies

This diet focuses on foods that complement GLP-1 medications, enhancing their effectiveness in managing appetite and improving metabolism